----
Neurocrine Biosciences (NBIX)
Neurocrine Biosciences, Inc. discovers, develops, and commercialize pharmaceuticals for neurological, psychiatric, endocrine, and immunological disorders in the...
- Open
- --
- High
- --
- Low
- --
- Prev. Close
- --
- Volume
- --
- Turnover
- --
- Avg Price
- --
- Bid/Ask Ratio
- --
- Amplitude
- --
- 52wk High
- --
- Volume Ratio
- --
- Turnover Ratio
- --
- 52wk Low
- --
- Float Mkt Cap
- --
- Market Cap
- --
- P/ETTM
- --
- P/EDynamic
- --
- P/EStatic
- --
- EPSTTM
- --
- EPSDynamic
- --
- EPSStatic
- --
- BVPS
- --
- P/B
- --
- Circulating Supply
- --
- Dividend YieldTTM
- --
- DividendTTM
- --
- Shares
- --
- Min lot size
- --
- Currency
- --
Neurocrine Biosciences Analyst Rating
View moreForecast & Rating
Nov 3, 2026Price forecast
$207.1525.66%
Forecast & RatingStrong buy
29analysts
- Strong buy72.41%
- Buy13.79%
- Hold13.79%
- Sell0.00%
- Strong sell0.00%
- Strong buy
- 21
- Buy
- 4
- Hold
- 4
- Sell
- 0
- Strong sell
- 0
